| Mild disease classification |
Mild degenerative cervical myelopathy is defined as an mJOA score of 15–17. |
Specialist assessment should document neurological function and interpret the score alongside symptoms, examination findings, and imaging. |
2017 clinical practice guideline |
| Severity boundaries |
Moderate disease: mJOA 12–14. Severe disease: mJOA 11 or lower. The maximum mJOA score is 18. |
Accurate severity classification helps distinguish mild disease from categories for which the guideline recommends surgery. |
2017 clinical practice guideline |
| Initial treatment options |
For mild disease, the guideline suggests offering surgery or a supervised trial of structured rehabilitation. |
Expert consultation should explain both options and incorporate symptoms, functional limitations, clinical findings, and patient preferences. |
Weak recommendation based on very low to low quality evidence. Guideline source |
| Neurological deterioration during nonoperative care |
If nonoperative management is selected, the guideline recommends surgery when neurological deterioration occurs. |
Follow-up should identify worsening hand function, walking ability, or other neurological findings and prompt reassessment. |
2017 clinical practice guideline |
| Failure to improve with nonoperative care |
The guideline suggests surgery if the patient fails to improve during nonoperative management. |
Specialists should reassess persistent functional limitations and discuss whether surgical decompression is appropriate. |
2017 clinical practice guideline |
| Published mild-disease surgical cohort |
A prospective multicenter study included 193 surgical patients with baseline mJOA scores of 15–17 and reported outcomes through 2 years. |
This provides a published reference for discussing postoperative outcomes in patients classified as having mild disease. |
Prospective cohort without a nonoperative comparison group. Badhiwala et al., 2019 |
| Neurological function after surgery |
Mean mJOA improvement at 2 years was +0.87 points in the mild-disease surgical cohort. |
Outcome discussions should account for the limited room for score improvement when baseline neurological scores are already high. |
Group mean change; individual outcomes vary. Badhiwala et al., 2019 |
| Neck-related disability after surgery |
Mean Neck Disability Index change at 2 years was −12.97 points. |
A lower score indicates less reported disability and complements neurological assessment when evaluating treatment outcomes. |
Reported in the same mild-disease surgical cohort. Badhiwala et al., 2019 |
| Gait-related functional outcome |
Mean Nurick grade change at 2 years was −1.13. |
A lower Nurick grade indicates improved function on a scale focused largely on walking impairment. |
Reported in the same mild-disease surgical cohort. Badhiwala et al., 2019 |
| Interpreting surgical outcome evidence |
The prospective cohort documented improvement after surgery but did not randomly compare surgery with structured rehabilitation. |
Clinical expertise includes explaining the limits of observational evidence when discussing expected benefits and treatment choices. |
Study-design limitation relevant to treatment comparisons. Badhiwala et al., 2019 |